LEO Pharma A/S

LEO Pharma helps people achieve healthy skin. The company is a leader in medical dermatology with a robust R&D pipeline, a wide range of therapies and a pioneering spirit. Founded in 1908 and owned by the LEO Foundation, LEO Pharma has devoted decades of research and development to advance the science of dermatology, setting new standards of care for people with skin conditions. LEO Pharma is headquartered in Denmark with a global team of 5,500 people, serving 76 million patients in 130 countries.

Role within BIOMAP

LEO Pharma will contribute scientific leadership and project management support to BIOMAP. We will provide project expertise in the Coordination Team and Executive Project Management Team and will serve as co-lead of WP7. LEO will also serve as industrial co-lead of the consortium and will serve on the Coordination Team and the Executive Project Management Team through co-leadership of WP1 and WP3. In addition, LEO will provide in-kind contributions in the form of expertise in data analytics, disease knowledge, and basic science. LEO will also contribute data from clinical studies in atopic dermatitis, including clinical and molecular data.